Praxis Precision Medicines, Inc.
NASDAQ:PRAX
76.52 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.302 | 0.357 | 0.431 | 0.515 | 0.468 | 0.781 | 0.683 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0.107 | 0.112 | 0.111 | 0.321 | 0.312 | 0.307 | 0.301 | 0.292 | 0.305 | 0.273 | 0.563 | 0.506 | 0.319 | 0.206 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0.302 | 0.25 | 0.319 | 0.404 | 0.147 | 0.469 | 0.376 | -0.301 | -0.292 | -0.305 | -0.273 | -0.563 | -0.506 | -0.319 | -0.206 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 1 | 0.7 | 0.74 | 0.784 | 0.314 | 0.601 | 0.551 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 41.881 | 27.26 | 26.984 | 18.388 | 17.26 | 25.614 | 25.504 | 28.329 | 30.439 | 43.62 | 52.652 | 43.511 | 33.139 | 25.678 | 17.929 | 16.272 | 12.786 | 9.05 | 6.868 | 5.699 | 9.346 | 7.256 | 7.256 |
| General & Administrative Expenses
| 15.256 | 10.585 | 15.333 | 9.933 | 8.724 | 10.127 | 13.27 | 13.124 | 13.851 | 16.774 | 16.197 | 15.146 | 11.634 | 10.805 | 9.49 | 9.44 | 3.431 | 2.52 | 1.601 | 1.795 | 1.308 | 1.565 | 1.565 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 15.256 | 10.585 | 15.333 | 9.933 | 8.724 | 10.127 | 13.27 | 13.124 | 13.851 | 16.774 | 16.197 | 15.146 | 11.634 | 10.805 | 9.49 | 9.44 | 3.431 | 2.52 | 1.601 | 1.795 | 1.308 | 1.565 | 1.565 |
| Other Expenses
| 0 | 4.811 | 2.333 | 0.928 | 0.884 | 0.648 | 0.636 | 0.28 | 0.345 | 0.2 | 0.132 | 0.07 | 0.073 | 0.082 | 0 | 0 | 0 | 0.005 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 57.137 | 37.845 | 42.317 | 28.321 | 25.984 | 35.741 | 38.774 | 41.453 | 44.29 | 60.394 | 68.849 | 58.657 | 44.773 | 36.483 | 27.419 | 25.712 | 16.217 | 11.57 | 8.469 | 7.494 | 10.654 | 8.821 | 8.821 |
| Operating Income
| -56.835 | -37.488 | -41.886 | -27.806 | -25.516 | -34.96 | -38.091 | -41.453 | -44.29 | -60.394 | -68.849 | -58.657 | -44.773 | -36.483 | -27.419 | -25.712 | -16.217 | -11.57 | -8.469 | -7.494 | -10.654 | -8.821 | -8.821 |
| Operating Income Ratio
| -188.195 | -105.008 | -97.183 | -53.992 | -54.521 | -44.763 | -55.77 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 4.925 | 4.811 | 2.333 | 0.928 | 0.884 | 0.648 | 0.636 | 0.28 | 0.345 | 0.2 | 0.132 | 0.07 | 0.073 | 0.082 | 0.046 | 0.006 | 0.001 | 0.005 | 0.128 | 0.022 | 0.048 | 0.062 | 0.062 |
| Income Before Tax
| -51.91 | -32.677 | -39.553 | -26.878 | -24.632 | -34.312 | -37.455 | -41.173 | -43.945 | -60.194 | -68.717 | -58.587 | -44.7 | -36.401 | -27.373 | -25.706 | -16.216 | -11.565 | -8.341 | -7.472 | -10.606 | -8.759 | -8.759 |
| Income Before Tax Ratio
| -171.887 | -91.532 | -91.77 | -52.19 | -52.632 | -43.933 | -54.839 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | -0.107 | -0.112 | 0.745 | -0.109 | -0.016 | -0.636 | -0.28 | -0.345 | -0.2 | -0.132 | -0.005 | 0.005 | -0.292 | -0.183 | 0.008 | 3.943 | 0.003 | -0.011 | -0.084 | 0 | 1.092 | 1.092 |
| Net Income
| -51.91 | -32.677 | -39.553 | -26.878 | -24.632 | -34.312 | -36.819 | -40.893 | -43.6 | -59.994 | -68.585 | -58.582 | -44.705 | -36.401 | -27.373 | -25.706 | -16.216 | -11.568 | -8.33 | -7.388 | -10.606 | -9.851 | -9.851 |
| Net Income Ratio
| -171.887 | -91.532 | -91.77 | -52.19 | -52.632 | -43.933 | -53.908 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -2.75 | -1.74 | -2.84 | -2.97 | -2.72 | -7.38 | -10.4 | -12.89 | -14.29 | -19.76 | -22.63 | -19.54 | -15 | -13.13 | -10.67 | -12.56 | -146.01 | -105.64 | -76.69 | -68.71 | -101.99 | -100.35 | -100.35 |
| EPS Diluted
| -2.75 | -1.74 | -2.84 | -2.97 | -2.72 | -7.38 | -10.4 | -12.89 | -14.29 | -19.76 | -22.63 | -19.54 | -15 | -13.13 | -10.67 | -12.56 | -146.01 | -105.64 | -76.69 | -68.71 | -101.99 | -100.35 | -100.35 |
| EBITDA
| -56.743 | -37.488 | -41.774 | -27.695 | -25.407 | -34.854 | -37.985 | -41.348 | -44.188 | -60.394 | -68.756 | -58.564 | -44.734 | -36.456 | -27.396 | -25.692 | -16.207 | -11.56 | -8.459 | -7.297 | -10.644 | -8.812 | -8.812 |
| EBITDA Ratio
| -187.891 | -105.008 | -97.183 | -53.777 | -54.521 | -44.627 | -55.77 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |